| Company/Division name | Nu-Tek BioSciences, LLC |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2021 |
| Domestically, the work will be done: | In-house |
| City reshored to: | Austin |
| State(s) reshored to: | MN |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals, biopharma |
| Product(s) reshored | animal-free peptone, protein hydrolysate, peptones |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption risk/Natural disaster risk/Political instability |
| What domestic positive factors made reshoring more attractive? | Infrastructure, Impact on domestic economy, Lead time/Time to market, Skilled workforce availability/training, Other, Covid-19, import replacement |
